Cargando…
Pleomorphic liposarcoma: An analysis of 6 case reports and literature review
RATIONALE: Pleomorphic liposarcoma (PLS), is a rare subtype of liposarcoma, and is considered to be of the highest malignancy grade. PATIENT CONCERNS: We aimed to analyze the clinical features, diagnosis, treatment, and recurrence of the 6 cases of PLS. DIAGNOSES: Six cases with confirmed pathologic...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841962/ https://www.ncbi.nlm.nih.gov/pubmed/29465602 http://dx.doi.org/10.1097/MD.0000000000009986 |
_version_ | 1783304828151136256 |
---|---|
author | Wang, Lianwei Luo, Runlan Xiong, Zuming Xu, Jinming Fang, Dengyang |
author_facet | Wang, Lianwei Luo, Runlan Xiong, Zuming Xu, Jinming Fang, Dengyang |
author_sort | Wang, Lianwei |
collection | PubMed |
description | RATIONALE: Pleomorphic liposarcoma (PLS), is a rare subtype of liposarcoma, and is considered to be of the highest malignancy grade. PATIENT CONCERNS: We aimed to analyze the clinical features, diagnosis, treatment, and recurrence of the 6 cases of PLS. DIAGNOSES: Six cases with confirmed pathological PLS presented at out hospital from January 2003 to January 2017. The postoperative pathology of 5 cases confirmed PLS, and the other was confirmed as PLS with well-differentiated liposarcoma. INTERVENTIONS: All 6 patients underwent complete tumor resection at the time of the first definite diagnosis, and one of them had underwent 3 cycles of chemotherapy treatment. OUTCOMES: There were 4 cases with local recurrence and surgery was repeated after the first radical excision. One case was not recurrent after 27 months post-operation, and the other was lost. The shortest recurrence time of all of these cases was 4 months, and the longest was 29 months after the first radical surgery. LESSONS: PLS is a rare and high-grade malignancy with high recurrence, poor prognosis, and its treatment is still highly controversial. More studies are required to determine the appropriate treatment and therapeutic strategies to improve the survival rate of patients with PLS, as the disease is associated with frequent relapse. |
format | Online Article Text |
id | pubmed-5841962 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-58419622018-03-13 Pleomorphic liposarcoma: An analysis of 6 case reports and literature review Wang, Lianwei Luo, Runlan Xiong, Zuming Xu, Jinming Fang, Dengyang Medicine (Baltimore) 5700 RATIONALE: Pleomorphic liposarcoma (PLS), is a rare subtype of liposarcoma, and is considered to be of the highest malignancy grade. PATIENT CONCERNS: We aimed to analyze the clinical features, diagnosis, treatment, and recurrence of the 6 cases of PLS. DIAGNOSES: Six cases with confirmed pathological PLS presented at out hospital from January 2003 to January 2017. The postoperative pathology of 5 cases confirmed PLS, and the other was confirmed as PLS with well-differentiated liposarcoma. INTERVENTIONS: All 6 patients underwent complete tumor resection at the time of the first definite diagnosis, and one of them had underwent 3 cycles of chemotherapy treatment. OUTCOMES: There were 4 cases with local recurrence and surgery was repeated after the first radical excision. One case was not recurrent after 27 months post-operation, and the other was lost. The shortest recurrence time of all of these cases was 4 months, and the longest was 29 months after the first radical surgery. LESSONS: PLS is a rare and high-grade malignancy with high recurrence, poor prognosis, and its treatment is still highly controversial. More studies are required to determine the appropriate treatment and therapeutic strategies to improve the survival rate of patients with PLS, as the disease is associated with frequent relapse. Wolters Kluwer Health 2018-02-23 /pmc/articles/PMC5841962/ /pubmed/29465602 http://dx.doi.org/10.1097/MD.0000000000009986 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0 |
spellingShingle | 5700 Wang, Lianwei Luo, Runlan Xiong, Zuming Xu, Jinming Fang, Dengyang Pleomorphic liposarcoma: An analysis of 6 case reports and literature review |
title | Pleomorphic liposarcoma: An analysis of 6 case reports and literature review |
title_full | Pleomorphic liposarcoma: An analysis of 6 case reports and literature review |
title_fullStr | Pleomorphic liposarcoma: An analysis of 6 case reports and literature review |
title_full_unstemmed | Pleomorphic liposarcoma: An analysis of 6 case reports and literature review |
title_short | Pleomorphic liposarcoma: An analysis of 6 case reports and literature review |
title_sort | pleomorphic liposarcoma: an analysis of 6 case reports and literature review |
topic | 5700 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841962/ https://www.ncbi.nlm.nih.gov/pubmed/29465602 http://dx.doi.org/10.1097/MD.0000000000009986 |
work_keys_str_mv | AT wanglianwei pleomorphicliposarcomaananalysisof6casereportsandliteraturereview AT luorunlan pleomorphicliposarcomaananalysisof6casereportsandliteraturereview AT xiongzuming pleomorphicliposarcomaananalysisof6casereportsandliteraturereview AT xujinming pleomorphicliposarcomaananalysisof6casereportsandliteraturereview AT fangdengyang pleomorphicliposarcomaananalysisof6casereportsandliteraturereview |